Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Laven, Anna (22634866000)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials
    (2020)
    Burckhardt, Bjoern B. (55383006300)
    ;
    Ciplea, Agnes Maria (57203856912)
    ;
    Laven, Anna (22634866000)
    ;
    Ablonczy, László (36636785400)
    ;
    Klingmann, Ingrid (6602830730)
    ;
    Läer, Stephanie (7003476724)
    ;
    Kleine, Karl (57209315896)
    ;
    Dalinghaus, Michiel (6601975474)
    ;
    Đukić, Milan (56835361300)
    ;
    Breur, Johannes M. P. J. (6506168146)
    ;
    van der Meulen, Marijke (57126909900)
    ;
    Swoboda, Vanessa (56465046300)
    ;
    Schwender, Holger (6506833490)
    ;
    Lagler, Florian B. (14061979400)
    Background: Pediatric trials to add missing data for evidence-based pharmacotherapy are still scarce. A tailored training concept appears to be a promising tool to cope with critical and complex situations before enrolling the very first patient and subsequently to ensure high-quality study conduct. The aim was to facilitate study success by optimizing the preparedness of the study staff shift. Method: An interdisciplinary faculty developed a simulation training focusing on the communication within the informed consent procedure and the conduct of the complex pharmacokinetic/pharmacodynamic (PK/PD) sampling within a simulation facility. Scenarios were video-debriefed by an audio-video system and manikins with artificial blood simulating patients were used. The training was evaluated by participants' self-assessment before and during trial recruitment. Results: The simulation training identified different optimization potentials for improved informed consent process and study conduct. It facilitated the reduction of avoidable errors, especially in the early phase of a clinical study. The knowledge gained through the intervention was used to train the study teams, improve the team composition and optimize the on-ward setting for the FP-7 funded “LENA” project (grant agreement no. 602295). Self-perceived ability to communicate core elements of the trial as well as its correct performance of sample preparation increased significantly (mean, 95% CI, p ≤ 0.0001) from 3 (2.5–3.5) to four points (4.0–4.5), and from 2 (1.5–2.5) to five points (4.0–5.0). Conclusion: An innovative training concept to optimize the informed consent process and study conduct was successfully developed and enabled high-quality conduct of the pediatric trials as of the very first patient visit. © Copyright © 2020 Burckhardt, Ciplea, Laven, Ablonczy, Klingmann, Läer, Kleine, Dalinghaus, Đukić, Breur, van der Meulen, Swoboda, Schwender and Lagler.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials
    (2020)
    Burckhardt, Bjoern B. (55383006300)
    ;
    Ciplea, Agnes Maria (57203856912)
    ;
    Laven, Anna (22634866000)
    ;
    Ablonczy, László (36636785400)
    ;
    Klingmann, Ingrid (6602830730)
    ;
    Läer, Stephanie (7003476724)
    ;
    Kleine, Karl (57209315896)
    ;
    Dalinghaus, Michiel (6601975474)
    ;
    Đukić, Milan (56835361300)
    ;
    Breur, Johannes M. P. J. (6506168146)
    ;
    van der Meulen, Marijke (57126909900)
    ;
    Swoboda, Vanessa (56465046300)
    ;
    Schwender, Holger (6506833490)
    ;
    Lagler, Florian B. (14061979400)
    Background: Pediatric trials to add missing data for evidence-based pharmacotherapy are still scarce. A tailored training concept appears to be a promising tool to cope with critical and complex situations before enrolling the very first patient and subsequently to ensure high-quality study conduct. The aim was to facilitate study success by optimizing the preparedness of the study staff shift. Method: An interdisciplinary faculty developed a simulation training focusing on the communication within the informed consent procedure and the conduct of the complex pharmacokinetic/pharmacodynamic (PK/PD) sampling within a simulation facility. Scenarios were video-debriefed by an audio-video system and manikins with artificial blood simulating patients were used. The training was evaluated by participants' self-assessment before and during trial recruitment. Results: The simulation training identified different optimization potentials for improved informed consent process and study conduct. It facilitated the reduction of avoidable errors, especially in the early phase of a clinical study. The knowledge gained through the intervention was used to train the study teams, improve the team composition and optimize the on-ward setting for the FP-7 funded “LENA” project (grant agreement no. 602295). Self-perceived ability to communicate core elements of the trial as well as its correct performance of sample preparation increased significantly (mean, 95% CI, p ≤ 0.0001) from 3 (2.5–3.5) to four points (4.0–4.5), and from 2 (1.5–2.5) to five points (4.0–5.0). Conclusion: An innovative training concept to optimize the informed consent process and study conduct was successfully developed and enabled high-quality conduct of the pediatric trials as of the very first patient visit. © Copyright © 2020 Burckhardt, Ciplea, Laven, Ablonczy, Klingmann, Läer, Kleine, Dalinghaus, Đukić, Breur, van der Meulen, Swoboda, Schwender and Lagler.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback